AGE OF DEMENTIA ONSET AND CARDIOVASCULAR RISK FACTORS
痴呆症发病年龄和心血管风险因素
基本信息
- 批准号:6808103
- 负责人:
- 金额:$ 36.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-15 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs diseaseage differenceapolipoprotein Ebiomarkerbody physical activitybody weightcardiovascular disordercase historycholesterolclinical researchcognition disordersdisease /disorder onsetdisease /disorder proneness /riskhomocysteinehuman genetic material taghuman old age (65+)human subjecthuman very old age (85+)hypertensionlongitudinal human studymagnetic resonance imagingmaleneuropsychological testsnoninsulin dependent diabetes mellitussmoking
项目摘要
Several ongoing longitudinal studies have found evidence that many cardiovascular disease risk factors (CvRFs) are also risk factors for Alzheimer disease (AD). Most study cohorts, however, do not include many of the oldest old, and when present, they are predominantly female. Data from our center suggest CvRFs may be especially potent for AD in the very old. We selected diabetes, total cholesterol, hypertension, and plasma homocysteine concentration, based on prior research, for primary hypothesis testing. We will investigate whether there is a relationship between each one of these four CvRFs with cognitive decline and AD in an elderly male veteran population and explore whether this effect is strengthened with increased age. An "Aging Research Clinic" will be established at the Bronx VA specifically dedicated to this project. Eligible
subjects must be older than 75 (with special emphasis on recruiting the very old) and be free of dementia. In addition to the four primary CvRFs, subjects will receive a comprehensive CvRF examination in conjunction with the cardiovascular research program at the Bronx VA. The four primary risk factors will be directly assessed at baseline in each subject. In addition, the baseline risk factor assessment will include: age, smoking, family history, weight and waistline, prior medical history for cardiovascular events, apolipoprotein E (and other relevant genotyping), C reactive protein, physical activity and other risk factors. Subjects will also be evaluated at baseline for left ventricular hypertrophy, carotid artery intima media thickness and proximal capacitative or large artery compliance, and distal oscillatory small artery compliance by radial artery pulse wave analysis. MRIs will be conducted at baseline in all subjects and at follow up in those who show evidence of cognitive decline (CDR30.5) to assess the role of cerebrovascular
disease. The subjects will be followed longitudinally on an annual basis to determine who among them show evidence of cognitive decline (CDR > or = 0.5) and AD, as well as other possible forms of dementias (e.g. vascular dementia). As many of these CvRFs are modifiable, implicating them as risk factors for very late onset cognitive decline and AD holds the potential for making major public health gains for the very old--the fastest growing segment of the U.S. population.
一些正在进行的纵向研究发现,许多心血管疾病风险因素(CvRF)也是阿尔茨海默病(AD)的风险因素。然而,大多数研究组群并不包括许多最年长的老人,即使有,也主要是女性。来自我们中心的数据表明,CvRFs可能对老年人的AD特别有效。我们根据先前的研究选择糖尿病、总胆固醇、高血压和血浆同型半胱氨酸浓度作为主要假设检验。我们将研究这四种CvRFs中的每一种与老年男性退伍军人群体中认知能力下降和AD之间是否存在关系,并探讨这种影响是否随着年龄的增长而加强。一个“老龄化研究诊所”将建立在布朗克斯弗吉尼亚州专门致力于这一项目。资格
受试者年龄必须超过75岁(特别强调招募高龄者),且无痴呆症。除了四项主要CvRF外,受试者还将接受全面的CvRF检查,并与布朗克斯VA的心血管研究项目联合进行。将在基线时直接评估每例受试者的四个主要风险因素。此外,基线风险因素评估将包括:年龄、吸烟、家族史、体重和腰围、既往心血管事件病史、载脂蛋白E(和其他相关基因分型)、C反应蛋白、体力活动和其他风险因素。还将在基线时通过桡动脉脉搏波分析评价受试者的左心室肥大、颈动脉内膜中层厚度和近端容量性或大动脉顺应性以及远端振荡性小动脉顺应性。所有受试者将在基线时进行MRI,显示认知下降证据的受试者将在随访时进行MRI(CDR 30.5),以评估脑血管疾病的作用。
疾病将每年对受试者进行纵向随访,以确定其中谁显示出认知下降(CDR >或= 0.5)和AD以及其他可能形式的痴呆(例如血管性痴呆)的证据。由于这些CvRF中的许多是可修改的,这意味着它们是极晚发性认知衰退的风险因素,而AD有可能为美国人口中增长最快的老年人带来重大的公共卫生收益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeremy M. Silverman其他文献
133 - Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disorders
- DOI:
10.1016/s0920-9964(97)82141-x - 发表时间:
1997-01-01 - 期刊:
- 影响因子:
- 作者:
Jeremy M. Silverman;Ge Li;Christopher J. Smith;Song Ling Guo;Richard C. Mohs;Larry J. Siever;Kenneth L. Davis - 通讯作者:
Kenneth L. Davis
Bmc Medical Genomics Multiplex Ligation-dependent Probe Amplification for Genetic Screening in Autism Spectrum Disorders: Efficient Identification of Known Microduplications and Identification of a Novel Microduplication in Asmt
Bmc Medical Genomics 用于自闭症谱系障碍基因筛查的多重连接依赖性探针扩增:有效鉴定已知微重复和鉴定 Asmt 中的新型微重复
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Guiqing Cai;Lisa J Edelmann;J. Goldsmith;Ninette Cohen;Alisa Nakamine;J. Reichert;Ellen J Hoffman;Danielle M Zurawiecki;Jeremy M. Silverman;Eric Hollander;L. Soorya;Evdokia Anagnostou;Catalina Betancur;Joseph D. Buxbaum;Jennifer G;Reichert;J Hoffman;M Zurawiecki;Jeremy M;Silverman;Catalina Betancur;Joseph D Fr;Buxbaum - 通讯作者:
Buxbaum
Bmc Medical Genetics Mutation Analysis of the Nsd1 Gene in Patients with Autism Spectrum Disorders and Macrocephaly
自闭症谱系障碍和大头畸形患者 Nsd1 基因的 Bmc 医学遗传学突变分析
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
J. Buxbaum;Guiqing Cai;G. Nygren;J. Goldsmith;M. Råstam;Jeremy M. Silverman;E. Hollander;C. Gillberg;M. Leboyer;C. Betancur;Groupe Hospitalier;Henri Mondor;Albert Chenevier;Email Joseph;Guiqing Edu;Cai;Nygren;Pauline Se;Chaste;R. Delorme;Juliet Fr;Com;Råstam;Jeremy M Se;Jeremy M. Silverman;Eric Edu;Hollander;Edu;Gillberg;Se;Leboyer Marion;Catalina Fr;Fr - 通讯作者:
Fr
Refining phenotype characterization in genetic linkage studies of schizophrenia.
精炼精神分裂症遗传连锁研究中的表型特征。
- DOI:
10.1080/19485565.1991.9988788 - 发表时间:
1991 - 期刊:
- 影响因子:0
- 作者:
R. S. Keefe;Jeremy M. Silverman;L. Siever;Barbara A. Cornblatt - 通讯作者:
Barbara A. Cornblatt
Jeremy M. Silverman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeremy M. Silverman', 18)}}的其他基金
Computerized Cognitive Training to Improve Cognition in Diabetic Elderly Veterans
计算机认知训练可提高患有糖尿病的老年退伍军人的认知能力
- 批准号:
10092822 - 财政年份:2014
- 资助金额:
$ 36.01万 - 项目类别:
Computerized Cognitive Training to Improve Cognition in Diabetic Elderly Veterans
计算机认知训练可提高患有糖尿病的老年退伍军人的认知能力
- 批准号:
9812757 - 财政年份:2014
- 资助金额:
$ 36.01万 - 项目类别:
Cardiovascular RF and Successful Cognitive Aging in Very Old Male Veterans
高龄男性退伍军人的心血管射频和成功的认知衰老
- 批准号:
8967190 - 财政年份:2014
- 资助金额:
$ 36.01万 - 项目类别:
Computerized Cognitive Training to Improve Cognition in Diabetic Elderly Veterans
计算机认知训练可提高患有糖尿病的老年退伍军人的认知能力
- 批准号:
8486136 - 财政年份:2014
- 资助金额:
$ 36.01万 - 项目类别:
Cardiovascular RF and Successful Cognitive Aging in Very Old Male Veterans
高龄男性退伍军人的心血管射频和成功的认知衰老
- 批准号:
9278085 - 财政年份:2014
- 资助金额:
$ 36.01万 - 项目类别:
Successful Cogn. Aging and Cardiovascular Risk Factors in the Central Valley CR
成功的科恩。
- 批准号:
8211241 - 财政年份:2012
- 资助金额:
$ 36.01万 - 项目类别:
Successful Cogn. Aging and Cardiovascular Risk Factors in the Central Valley CR
成功的科恩。
- 批准号:
8445210 - 财政年份:2012
- 资助金额:
$ 36.01万 - 项目类别:
Autistic endophenotypes and their associations to oxytocin and cholesterol
自闭症内表型及其与催产素和胆固醇的关联
- 批准号:
7895674 - 财政年份:2009
- 资助金额:
$ 36.01万 - 项目类别:
Autistic endophenotypes and their associations to oxytocin and cholesterol
自闭症内表型及其与催产素和胆固醇的关联
- 批准号:
7737908 - 财政年份:2009
- 资助金额:
$ 36.01万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 36.01万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 36.01万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 36.01万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 36.01万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 36.01万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 36.01万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 36.01万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 36.01万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 36.01万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 36.01万 - 项目类别:














{{item.name}}会员




